151 related articles for article (PubMed ID: 11441014)
1. Transmembrane domains 4 and 7 of the M(1) muscarinic acetylcholine receptor are critical for ligand binding and the receptor activation switch.
Lu ZL; Saldanha JW; Hulme EC
J Biol Chem; 2001 Sep; 276(36):34098-104. PubMed ID: 11441014
[TBL] [Abstract][Full Text] [Related]
2. Structure and activation of muscarinic acetylcholine receptors.
Hulme EC; Lu ZL; Saldanha JW; Bee MS
Biochem Soc Trans; 2003 Feb; 31(Pt 1):29-34. PubMed ID: 12546648
[TBL] [Abstract][Full Text] [Related]
3. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor.
Han SJ; Hamdan FF; Kim SK; Jacobson KA; Bloodworth LM; Li B; Wess J
J Biol Chem; 2005 Oct; 280(41):34849-58. PubMed ID: 16093246
[TBL] [Abstract][Full Text] [Related]
4. A network of conserved intramolecular contacts defines the off-state of the transmembrane switch mechanism in a seven-transmembrane receptor.
Lu ZL; Hulme EC
J Biol Chem; 2000 Feb; 275(8):5682-6. PubMed ID: 10681552
[TBL] [Abstract][Full Text] [Related]
5. The functional topography of transmembrane domain 3 of the M1 muscarinic acetylcholine receptor, revealed by scanning mutagenesis.
Lu ZL; Hulme EC
J Biol Chem; 1999 Mar; 274(11):7309-15. PubMed ID: 10066794
[TBL] [Abstract][Full Text] [Related]
6. Alanine-scanning mutagenesis of transmembrane domain 6 of the M(1) muscarinic acetylcholine receptor suggests that Tyr381 plays key roles in receptor function.
Ward SD; Curtis CA; Hulme EC
Mol Pharmacol; 1999 Nov; 56(5):1031-41. PubMed ID: 10531410
[TBL] [Abstract][Full Text] [Related]
7. Scanning mutagenesis identifies amino acid side chains in transmembrane domain 5 of the M(1) muscarinic receptor that participate in binding the acetyl methyl group of acetylcholine.
Allman K; Page KM; Curtis CA; Hulme EC
Mol Pharmacol; 2000 Jul; 58(1):175-84. PubMed ID: 10860940
[TBL] [Abstract][Full Text] [Related]
8. Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor.
Hamdan FF; Ward SD; Siddiqui NA; Bloodworth LM; Wess J
Biochemistry; 2002 Jun; 41(24):7647-58. PubMed ID: 12056896
[TBL] [Abstract][Full Text] [Related]
9. The conformational switch in muscarinic acetylcholine receptors.
Hulme EC; Lu ZL; Bee M; Curtis CA; Saldanha J
Life Sci; 2001 Apr; 68(22-23):2495-500. PubMed ID: 11392618
[TBL] [Abstract][Full Text] [Related]
10. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
[TBL] [Abstract][Full Text] [Related]
11. Scanning mutagenesis of transmembrane domain 3 of the M1 muscarinic acetylcholine receptor.
Hulme EC; Lu ZL
J Physiol Paris; 1998; 92(3-4):269-74. PubMed ID: 9789821
[TBL] [Abstract][Full Text] [Related]
12. Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast. Identification of point mutations that "silence" a constitutively active mutant M3 receptor and greatly impair receptor/G protein coupling.
Schmidt C; Li B; Bloodworth L; Erlenbach I; Zeng FY; Wess J
J Biol Chem; 2003 Aug; 278(32):30248-60. PubMed ID: 12750375
[TBL] [Abstract][Full Text] [Related]
13. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function.
Lee SY; Zhu SZ; el-Fakahany EE
Recept Signal Transduct; 1996; 6(1):43-52. PubMed ID: 8933621
[TBL] [Abstract][Full Text] [Related]
14. Role of conserved threonine and tyrosine residues in acetylcholine binding and muscarinic receptor activation. A study with m3 muscarinic receptor point mutants.
Wess J; Maggio R; Palmer JR; Vogel Z
J Biol Chem; 1992 Sep; 267(27):19313-9. PubMed ID: 1527051
[TBL] [Abstract][Full Text] [Related]
15. Roof and floor of the muscarinic binding pocket: variations in the binding modes of orthosteric ligands.
Goodwin JA; Hulme EC; Langmead CJ; Tehan BG
Mol Pharmacol; 2007 Dec; 72(6):1484-96. PubMed ID: 17848601
[TBL] [Abstract][Full Text] [Related]
16. Scanning mutagenesis studies of the M1 muscarinic acetylcholine receptor.
Hulme EC; Lu ZL; Bee MS
Recept Channels; 2003; 9(4):215-28. PubMed ID: 12893535
[TBL] [Abstract][Full Text] [Related]
17. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
Peng JY; Vaidehi N; Hall SE; Goddard WA
ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
[TBL] [Abstract][Full Text] [Related]
18. Helix 8 of the M1 muscarinic acetylcholine receptor: scanning mutagenesis delineates a G protein recognition site.
Kaye RG; Saldanha JW; Lu ZL; Hulme EC
Mol Pharmacol; 2011 Apr; 79(4):701-9. PubMed ID: 21247934
[TBL] [Abstract][Full Text] [Related]
19. Conserved extracellular cysteine pair in the M3 muscarinic acetylcholine receptor is essential for proper receptor cell surface localization but not for G protein coupling.
Zeng FY; Soldner A; Schöneberg T; Wess J
J Neurochem; 1999 Jun; 72(6):2404-14. PubMed ID: 10349850
[TBL] [Abstract][Full Text] [Related]
20. Conformational changes that occur during M3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross-linking strategy.
Ward SD; Hamdan FF; Bloodworth LM; Wess J
J Biol Chem; 2002 Jan; 277(3):2247-57. PubMed ID: 11698401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
